Seth Zuckerman

Seth Zuckerman is a seasoned professional in biostatistics with extensive experience across various roles in the pharmaceutical and clinical research industries. Currently serving as Sr. Director of Biostatistics at Galectin Therapeutics since July 2023, Seth previously held multiple positions at Cytel from May 2010 to July 2023, culminating in the role of Senior Director Biostatistics. Earlier experience includes serving as Principal Statistician at sanofi-aventis, Statistical Consultant while self-employed, and Statistical Scientist at AstraZeneca. Starting a career at Kendle International Inc as Lead Clinical Research Associate and as Clinical Data Team Leader at Centocor, Seth holds an MS in Statistics from the Fox School of Business at Temple University and a BS in Biology from Gettysburg College.